Search results
A shot in the arm that can help fight cancer? How vaccine trials are showing promise.
USA TODAY via Yahoo News· 19 hours agoSo close, but not close enough for everyone Even with this type of cancer vaccine, though,...
Cancer patients often do better with less intensive treatment, research shows
NBC NEWS· 2 days agoScaling back treatment for three kinds of cancer can make life easier for patients without...
ASCO 2024: Precede Biosciences assay classifies HER2 and ER status in cancers
Clinical Trials Arena via Yahoo Finance· 2 days agoThe second showed that ER status was accurately assessed, and the level of ER pathway activation was...
Team presents promising results from first clinical trial of next-gen antibody in patients with...
Medical Xpress· 2 days agoThe ongoing trial has already included 104 patients with various types of tumors who had received between one and seven previous courses of treatment. Preliminary results from this phase 1 trial ...
Galapagos selects Adaptimmune T-cell therapy for $665M biobucks collab
FierceBiotech· 5 days agoThe multipronged deal, announced after market close Thursday, involves uza-cel, a MAGE-A4 TCR T-cell...
...Exclusively License Adaptimmune's TCR T-cell Therapy Candidate, uza-cel, in Head & Neck Cancer...
Digital Journal· 6 days agoAdaptimmune and Galapagos to conduct clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel (next-generation MAGE-A4 TCR T-cell therapy) produced on ...
Multicancer early detection tests for cancer diagnosis
Medical Xpress· 5 days agoCancer is characterized by the uncontrolled proliferation and spread of abnormal cells within the body. Malignant tumors, unlike benign ones, invade nearby tissues and spread ...
Six cancer treatment breakthroughs pushing us closer to a cure
The Telegraph via Yahoo News· 5 days agoWhat will it treat? PCNA is found in all cancers, and AOH1996 has shown promise in 70 cell lines,...
Gene variants foretell the biology of future breast cancers, study finds
Medical Xpress· 6 days ago"Apart from a few highly penetrant genes that confer significant cancer risk, the role of heredity factors remains poorly understood, and most malignancies are assumed to ...
ComboMATCH Precision Medicine Cancer Trials
National Cancer Institute· 18 hours agoComboMATCH (Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice) is a group of precision medicine cancer clinical trials,...